Seattle Genetics signs development deal with Glaxo (AP via Yahoo! Finance)

December 21st, 2009 by admin

Biotechnology company Seattle Genetics Inc. said Monday it will receive $12 million upfront as it licenses its cancer-fighting technology to GlaxoSmithKline.

This entry was posted on Monday, December 21st, 2009 at 8:10 pm and is filed under Genetics, Human Genetics. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.

Comments are closed.